RESP301

· Thirty Respiratory Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RESP301, covering 2022-06-02 to 2025-07-15. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With Tuberculosis [Phase 2]

See pricing